相关实验视频

Updated: Nov 21, 2025

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.6K

在小儿神经母细胞瘤CAR-T治疗试验中发现了不同的结果

Jennifer Abbasi

    JAMA
    |January 12, 2021
    PubMed
    概括

    No abstract available in PubMed .

    更多相关视频

    Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice
    05:22

    Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

    Published on: February 24, 2023

    3.8K
    Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
    09:06

    Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

    Published on: November 11, 2021

    2.8K

    相关实验视频

    Last Updated: Nov 21, 2025

    Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
    09:34

    Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

    Published on: February 17, 2022

    3.6K
    Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice
    05:22

    Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

    Published on: February 24, 2023

    3.8K
    Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
    09:06

    Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

    Published on: November 11, 2021

    2.8K

    相关概念视频

    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    3.5K
    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    3.5K
    JoVE
    关于 JoVE
    概览领导团队博客JoVE 帮助中心
    作者
    出版流程编辑委员会范围与政策同行评审常见问题投稿
    图书馆员
    用户评价订阅访问资源图书馆顾问委员会常见问题
    研究
    JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
    教育
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
    使用条款与条件
    隐私政策
    政策
    Jove
    Visualize
    联系我们